Aimed Bio Inc. (KOSDAQ:0009K0)

Aimed Bio Statistics

Total Valuation

Aimed Bio has a market cap or net worth of KRW 2.18 trillion. The enterprise value is 2.10 trillion.

Market Cap	2.18T
Enterprise Value	2.10T

Important Dates

The next estimated earnings date is Thursday, August 13, 2026.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Aimed Bio has 64.67 million shares outstanding. The number of shares has increased by 60.49% in one year.

Current Share Class	64.67M
Shares Outstanding	64.67M
Shares Change (YoY)	+60.49%
Shares Change (QoQ)	-10.52%
Owned by Insiders (%)	34.37%
Owned by Institutions (%)	10.39%
Float	22.61M

Valuation Ratios

The trailing PE ratio is 535.77 and the forward PE ratio is 198.53.

PE Ratio	535.77
Forward PE	198.53
PS Ratio	40.27
PB Ratio	11.37
P/TBV Ratio	11.47
P/FCF Ratio	176.57
P/OCF Ratio	166.16
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 108.18, with an EV/FCF ratio of 169.98.

EV / Earnings	515.77
EV / Sales	38.77
EV / EBITDA	108.18
EV / EBIT	117.11
EV / FCF	169.98

Financial Position

The company has a current ratio of 14.27, with a Debt / Equity ratio of 0.01.

Current Ratio	14.27
Quick Ratio	12.72
Debt / Equity	0.01
Debt / EBITDA	0.09
Debt / FCF	0.14
Interest Coverage	181.73

Financial Efficiency

Return on equity (ROE) is 3.44% and return on invested capital (ROIC) is 9.39%.

Return on Equity (ROE)	3.44%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.39%
Return on Capital Employed (ROCE)	9.29%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-9.18B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	45,121.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	33.75
Average Volume (20 Days)	225,341

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aimed Bio had revenue of KRW 54.20 billion and earned 4.07 billion in profits. Earnings per share was 71.30.

Revenue	54.20B
Gross Profit	54.20B
Operating Income	17.94B
Pretax Income	-5.11B
Net Income	4.07B
EBITDA	19.42B
EBIT	17.94B
Earnings Per Share (EPS)	71.30

Balance Sheet

The company has 83.28 billion in cash and 1.77 billion in debt, with a net cash position of 81.50 billion or 1,260.28 per share.

Cash & Cash Equivalents	83.28B
Total Debt	1.77B
Net Cash	81.50B
Net Cash Per Share	1,260.28
Equity (Book Value)	191.90B
Book Value Per Share	2,959.01
Working Capital	90.30B

Cash Flow

In the last 12 months, operating cash flow was 13.14 billion and capital expenditures -774.59 million, giving a free cash flow of 12.36 billion.

Operating Cash Flow	13.14B
Capital Expenditures	-774.59M
Depreciation & Amortization	1.48B
Net Borrowing	-606.12M
Free Cash Flow	12.36B
FCF Per Share	191.14

Margins

Gross margin is 100.00%, with operating and profit margins of 33.11% and 7.52%.

Gross Margin	100.00%
Operating Margin	33.11%
Pretax Margin	-9.43%
Profit Margin	7.52%
EBITDA Margin	35.84%
EBIT Margin	33.11%
FCF Margin	22.81%

Dividends & Yields

Aimed Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-60.49%
Shareholder Yield	-60.49%
Earnings Yield	0.19%
FCF Yield	0.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aimed Bio has an Altman Z-Score of 278.56 and a Piotroski F-Score of 3.

Altman Z-Score	278.56
Piotroski F-Score	3